Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT Trial
In young people with T1D and markedly elevated glycemia, longer term AID use with MM780G provided substantial, sustained improvements in glycemia without compromising safety. These findings support broader AID adoption in this high-risk population (Australian New Zealand Clinical Trials Registry number ACTRN12622001454763).
Authors
- C. Jefferies
- Jillian Joy Haszard (ORCID: https://orcid.org/0000-0001-6312-7795)
- Caleb A Lopez-Sanchez
- Marcus C Ward
- Alisa Boucsein
- Yongwen Zhou
- Ryan G. Paul
- Benjamin J. Wheeler
- Esko J. Wiltshire
- Martin I. de Bock
- Venus R. Michaels
Institutions
- University of Auckland (NZ)
- Sun Yat-sen University (CN)
- Southern District Health Board (NZ)
- Starship Children's Health (NZ)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- University of Waikato (NZ)
- University of Otago (NZ)
Publication Details
- Journal
- Diabetes Technology & Therapeutics
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1177/15209156261426883
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00